UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Correlation between Loss of PTEN Expression and Akt Phosphorylation in Endometrial Carcinoma

Clinical cancer research, 2001-04, Vol.7 (4), p.892-895

2001

Volltextzugriff (PDF)

1579 Efficacy and safety of olanzapine combined with aprepitant, palonosetron, and dexamethasone for preventing nausea and vomiting induced by cisplatin-based chemotherapy in gynecological cancer: Comparison of two prospective phase II trials

European journal of cancer (1990), 2015-09, Vol.51, p.S230-S231

2015

Volltextzugriff (PDF)

Galectin‐3 may contribute to Cisplatin resistance in clear cell carcinoma of the ovary

International journal of gynecological cancer, 2007-09, Vol.17 (5), p.1040-1046

2007

Volltextzugriff (PDF)

Nedaplatin: a cisplatin derivative in cancer chemotherapy

Cancer management and research, 2013, Vol.5 (default), p.67-76

2013

Volltextzugriff (PDF)

Antitumor effect of E1A in ovarian cancer by cytoplasmic sequestration of activated ERK by PEA15

Oncogene, 2006-01, Vol.25 (1), p.79-90

2006

Volltextzugriff (PDF)

Prognosis and clinicopathological characteristics of Ib-IIb adenocarcinoma of the uterine cervix in patients who have had radical hysterectomy

European journal of surgical oncology, 2000-08, Vol.26 (5), p.464-467

2000

Volltextzugriff (PDF)

Chemosensitivity and p53–Bax pathway-mediated apoptosis in patients with uterine cervical cancer

Annals of oncology, 2003-02, Vol.14 (2), p.214-219

2003

Volltextzugriff (PDF)

Profile of farletuzumab and its potential in the treatment of solid tumors

OncoTargets and therapy, 2016-01, Vol.9 (Issue 1), p.1181-1188

2016

Volltextzugriff (PDF)

Genetic diagnosis for chemosensitivity with drug‐resistance genes in epithelial ovarian cancer

International journal of gynecological cancer, 2007-01, Vol.17 (1), p.76-82

2007

Volltextzugriff (PDF)

Phase 1/2 trials of peptides cocktail vaccine for resistant cervical and ovarian cancer: Qol analysis

Annals of oncology, 2017-09, Vol.28, p.v345-v346

2017

Volltextzugriff (PDF)

Loss of ARID1A expression is associated with poor prognosis in patients with stage I/II clear cell carcinoma of the ovary

Annals of oncology, 2016-10, Vol.27, p.vi303-vi303

2016

Volltextzugriff (PDF)

Fibroblast Growth Factor Receptor 2 Expression May Be Involved In Transformation of Ovarian Endometrioma to Clear Cell Carcinoma of the Ovary

International journal of gynecological cancer, 2013-06, Vol.23 (5), p.791-796

2013

Volltextzugriff (PDF)

p53 gene status and chemosensitivity in ovarian cancer

Human cell : official journal of Human Cell Research Society, 2001-09, Vol.14 (3), p.165-171

2001

Volltextzugriff (PDF)

Reduction of radiation-induced apoptosis by specific expression of Bcl-2 in normal cells

Cancer gene therapy, 2006-05, Vol.13 (5), p.451-459

2006

Volltextzugriff (PDF)

Effect of simple omentoplasty and omentopexy in the prevention of complications after pelvic lymphadenectomy

International journal of gynecological cancer, 2003-01, Vol.13 (1), p.61-66

2003

Volltextzugriff (PDF)

Low proliferation activity may be associated with chemoresistance in clear cell carcinoma of the ovary

Obstetrics and gynecology (New York. 1953), 2002-08, Vol.100 (2), p.281-287

2002

Volltextzugriff (PDF)

Outcome of patients with early ovarian cancer undergoing three courses of adjuvant chemotherapy following complete surgical staging

International journal of gynecological cancer, 2005-07, Vol.15 (4), p.601-605

2005

Volltextzugriff (PDF)

Intraperitoneal carboplatin infusion may be a pharmacologically more reasonable route than intravenous administration as a systemic chemotherapy. A comparative pharmacokinetic analysis of platinum using a new mathematical model after intraperitoneal vs. intravenous infusion of carboplatin—A Sankai Gynecology Study Group (SGSG) study

Gynecologic oncology, 2005-12, Vol.99 (3), p.591-596

2005

Volltextzugriff (PDF)

0114: Adenovirus Type 5 E1A Gene Therapy for Ovarian Clear Cell Carcinoma: a Potential Treatment Strategy

International journal of gynecological cancer, 2006-10, Vol.16 (Suppl 3), p.632-633

2006

Volltextzugriff (PDF)

Multidrug Resistance Gene-1 Is a Useful Predictor of Paclitaxel-Based Chemotherapy for Patients with Ovarian Cancer

Gynecologic oncology, 2002-08, Vol.86 (2), p.171-176

2002

Volltextzugriff (PDF)

Telomerase activity and p53-dependent apoptosis in ovarian cancer cells

British journal of cancer, 2001-06, Vol.84 (11), p.1551-1555

2001

Volltextzugriff (PDF)

Outcome of patients with early ovarian cancer undergoing three courses of adjuvant chemotherapy following complete surgical staging

International journal of gynecological cancer, 2005-06, Vol.15 (4), p.601-605

2005

Volltextzugriff (PDF)

The role of topoisomerase I inhibitor in cisplatin-resistant ovarian cancer

Human cell : official journal of Human Cell Research Society, 2001-09, Vol.14 (3), p.237

2001

Volltextzugriff (PDF)

Mechanism of the combination effect of wild-type TP53 gene transfection and cisplatin treatment for ovarian cancer xenografts

European journal of cancer (1990), 2000-09, Vol.36 (14), p.1869-1875

2000

Volltextzugriff (PDF)

The outcome of radiation therapy in elderly patients with advanced cervical cancer

International journal of gynecology and obstetrics, 1997-09, Vol.58 (3), p.305-309

1997

Volltextzugriff (PDF)

1 – 25 von 72

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70)
Mit Volltextzugriff
(55)

Publikationsform

Artikel
(72)

Sprache

Englisch
(71)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Correlation between Loss of PTEN Expression and Akt Phosphorylation in Endometrial Carcinoma

1579 Efficacy and safety of olanzapine combined with aprepitant, palonosetron, and dexamethasone for preventing nausea and vomiting induced by cisplatin-based chemotherapy in gynecological cancer: Comparison of two prospective phase II trials

Galectin‐3 may contribute to Cisplatin resistance in clear cell carcinoma of the ovary

Nedaplatin: a cisplatin derivative in cancer chemotherapy

Antitumor effect of E1A in ovarian cancer by cytoplasmic sequestration of activated ERK by PEA15

Prognosis and clinicopathological characteristics of Ib-IIb adenocarcinoma of the uterine cervix in patients who have had radical hysterectomy

Chemosensitivity and p53–Bax pathway-mediated apoptosis in patients with uterine cervical cancer

Profile of farletuzumab and its potential in the treatment of solid tumors

Genetic diagnosis for chemosensitivity with drug‐resistance genes in epithelial ovarian cancer

Phase 1/2 trials of peptides cocktail vaccine for resistant cervical and ovarian cancer: Qol analysis

Loss of ARID1A expression is associated with poor prognosis in patients with stage I/II clear cell carcinoma of the ovary

Fibroblast Growth Factor Receptor 2 Expression May Be Involved In Transformation of Ovarian Endometrioma to Clear Cell Carcinoma of the Ovary

p53 gene status and chemosensitivity in ovarian cancer

Reduction of radiation-induced apoptosis by specific expression of Bcl-2 in normal cells

Effect of simple omentoplasty and omentopexy in the prevention of complications after pelvic lymphadenectomy

Low proliferation activity may be associated with chemoresistance in clear cell carcinoma of the ovary

Outcome of patients with early ovarian cancer undergoing three courses of adjuvant chemotherapy following complete surgical staging

0114: Adenovirus Type 5 E1A Gene Therapy for Ovarian Clear Cell Carcinoma: a Potential Treatment Strategy

Multidrug Resistance Gene-1 Is a Useful Predictor of Paclitaxel-Based Chemotherapy for Patients with Ovarian Cancer

Telomerase activity and p53-dependent apoptosis in ovarian cancer cells

Outcome of patients with early ovarian cancer undergoing three courses of adjuvant chemotherapy following complete surgical staging

The role of topoisomerase I inhibitor in cisplatin-resistant ovarian cancer

Mechanism of the combination effect of wild-type TP53 gene transfection and cisplatin treatment for ovarian cancer xenografts

The outcome of radiation therapy in elderly patients with advanced cervical cancer

Suchergebnisse filtern